COLORECTUM+ Digital System for Postoperative Quality Improvement in Colorectal Cancer
Recruiting now · Not applicable
Conditions studied: Colorectal Carcinoma
In brief
This is a single-center, prospective, interventional study. A total of 236 colorectal cancer patients who underwent surgery will be enrolled and followed for 52 weeks. The digital healthcare quality management system, based on the COLORECTUM+ model, will be used for post-treatment quality evaluation and continuous improvement. Patients will be managed using an Internet+ post-treatment healthcare management platform. The platform integrates AI technology for real-time symptom analysis and alerts. Patients will report symptoms and health data through the platform, which will generate alerts based on symptom severity to guide appropriate interventions. Follow-up assessments will include patient adherence, satisfaction, quality of life, and healthcare utilization. The study expects to demonstrate that the digital healthcare quality management system improves follow-up rates, enhances patient adherence, reduces unplanned hospital visits, and increases overall patient satisfaction. The findings aim to provide evidence for the implementation of digital management systems in colorectal cancer post-treatment care, potentially leading to improved long-term outcomes for patients.
Key facts
- Study ID
- NCT06685497
- Run by
- RenJi Hospital
- People needed
- 236
- Starts
- 2024-12-01
- Expected to finish
- 2028-06-01
- Last updated by the study team
- 2026-07-28
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Over 18 years old.
- Pathologically confirmed colorectal cancer patients.
- Underwent surgery at the Colorectal Cancer Diagnosis and Treatment Center, Gastrointestinal Surgery, Renji Hospital, Shanghai Jiao Tong University School of Medicine.
- Signed informed consent form.
You may not qualify if…
- Unable to access electronic devices that can connect to the internet or mobile communications.
- Uncontrolled psychiatric illness.
- The ECOG score is greater than or equal to 3.
- Deemed unsuitable for participation by the investigator.
Where it is running
- Shanghai Jiao Tong University School of Medicine, Renji Hospital — Shanghai, China (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.